Tardive dyskinesia (TD) is one of the most serious and disturbing side-effects of dopamine
receptor antagonists. It affects 20-50% of patients on long-term antipsychotic therapy. The …

Tardive dyskinesia (TD) is characterized by abnormal and involuntary movements that
generally occur after prolonged exposure to neuroleptic medications. In this article, we …

Tardive dyskinesia (TD) is a disfiguring side-effect of antipsychotic medications that is
potentially irreversible in affected patients. Newer atypical antipsychotics are felt by many to …

Tardive dyskinesia (TD) is a devastating adverse effect of long-term antipsychotic drug
treatment. Atypical antipsychotics produce less TD, and it has been shown that they may …

Background Tardive dyskinesia (TD) is a severe condition that can affect almost 1 out of 4
patients on current or previous antipsychotic treatment, including both first-generation …

Tardive dyskinesias (TD) are serious, often irreversible side effects of dopamine blocking
agents, most commonly first-generation antipsychotics. No definitive treatment exists, with …

Background Long-term use of antipsychotics or other dopamine antagonists can result in the
extrapyramidal side effect of tardive dyskinesia (TD). Case presentation: An 18-year-old …

Tardive dyskinesia (TD) is a movement disorder that presents with abnormal, involuntary,
and irregular choreoathetoid movements involving mouth, tongue, face, trunk, or extremities …

Tardive dyskinesia (TD) is a serious, often disabling, movement disorder that is caused by
medications that block dopamine receptors (ie, neuroleptics, anti-emetics). There is currently …

Tardive dyskinesia (TD) is a potentially permanent movement disorder resulting from chronic
use of dopamine receptor blocking agents (DRBA). Identified risk factors include the type of …